UNAIDS. Global AIDS update: seizing the moment—tackling entrenched inequalities to end epidemics. Geneva: UNAIDS; 2020.
Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.
Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423–34.
World Health Organization (WHO). WHO expands commendation on oral pre-exposure prophylaxis of HIV infection. Geneva: World Health Organization; 2016.
Calabrese SK, Dovidio JF, Tekeste M, Taggart T, Galvao RW, Safon CB, et al. HIV pre-exposure prophylaxis stigma as a multidimensional barrier to uptake among women who attend planned parenthood. J Acquir Immune Defic Syndr. 2018;79(1):46–53.
Golub SA, Fikslin RA, Goldberg MH, Peña SM, Radix A. Predictors of PrEP uptake among patients with equivalent access. AIDS Behav. 2019;23(7):1917–24.
Velloza J, Khoza N, Scorgie F, Chitukuta M, Mutero P, Mutiti K, et al. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study. J Int AIDS Soc. 2020. https://doi.org/10.1002/jia2.25463.
McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53–60.
Stadler J, Delany-Moretlwe S, Palanee T, Rees H. Hidden harms: women’s narratives of intimate partner violence in a microbicide trial, South Africa. Soc Sci Med. 2014;110:49–55.
Sidebottom D, Ekström A, Strömdahl S. A systematic review of adherence to oral pre-exposure prophylaxis for HIV—how can we improve uptake and adherence? BMC Infect Dis. 2018. https://doi.org/10.1186/s12879-018-3463-4.
Calabrese SK, Underhill K. How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: a call to destigmatize “Truvada Whores.” Am J Public Health. 2015;105(10):1960–4.
Goffman E. Stigma: notes on the management of spoiled identity. New York: Simon & Schuster; 1963.
Haire BG. Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence—a narrative review. HIV AIDS (Auckl). 2015;7:241–9.
Stangl AL, Earnshaw VA, Logie CH, Van Brakel W, Simbayi LC, Barré I, et al. The Health Stigma and Discrimination Framework: a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas. BMC Med. 2019;17(1): a31.
Golub SA, Gamarel KE, Surace A. Demographic differences in PrEP-related stereotypes: implications for implementation. AIDS Behav. 2017;21(5):1229–35.
Mutchler MG, McDavitt B, Ghani MA, Nogg K, Winder TJA, Soto JK. Getting PrEPared for HIV prevention navigation: young black gay men talk about HIV prevention in the biomedical era. AIDS Patient Care STDS. 2015;29(9):490–502.
Storholm ED, Volk JE, Marcus JL, Silverberg MJ, Satre DD. Risk perception, sexual behaviors, and PrEP adherence among substance-using men who have sex with men: a qualitative study. Prev Sci. 2017;18(6):737–47.
Haberer JE. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice. Curr Opin HIV AIDS. 2016;11:10–7.
Van Der Straten A, Stadler J, Montgomery E, Hartmann M, Magazi B, Mathebula F, et al. Women’s experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. PLoS ONE. 2014;9(2):e89118.
Corneli A, Perry B, McKenna K, Agot K, Ahmed K, Taylor J, et al. Participants’ explanations for nonadherence in the FEM-PrEP clinical trial. J Acquir Immune Defic Syndr. 2016;71:452–61.
Montgomery ET, van der Straten A, Stadler J, Hartmann M, Magazi B, Mathebula F, et al. Male partner influence on women’s HIV prevention trial participation and use of pre-exposure prophylaxis: the importance of “Understanding.” AIDS Behav. 2015;19(5):784–93.
Van Der Elst EM, Mbogua J, Operario D, Mutua G, Kuo C, Mugo P, et al. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav. 2013;17(6):2162–72.
Tangmunkongvorakul A, Chariyalertsak S, Rivet Amico K, Saokhieo P, Wannalak V, Sangangamsakun T, et al. Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand. AIDS Care. 2013;25(8):961–7.
van der Straten A, Stadler J, Luecke E, Laborde N, Hartmann M, Montgomery ET. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa. J Int AIDS Soc. 2014. https://doi.org/10.7448/IAS.17.3.19146.
Scorgie F, Khoza N, Baron D, Lees S, Harvey S, Ramskin L, et al. Disclosure of PrEP use by young women in South Africa and Tanzania: qualitative findings from a demonstration project. Cult Health Sex. 2021;23(2):257–72.
Geary CW, Bukusi EA. Women and ARV-based HIV prevention—challenges and opportunities. J Int AIDS Soc. 2014. https://doi.org/10.7448/IAS.17.3.19356.
Mustanski B, Ryan DT, Hayford C, Phillips G, Newcomb ME, Smith JD. Geographic and individual associations with PrEP stigma: results from the RADAR cohort of diverse young men who have sex with men and transgender women. AIDS Behav. 2018. https://doi.org/10.1007/s10461-018-2159-5.
Klein H, Washington TA. The Pre-Exposure Prophylaxis (PrEP) Stigma Scale: preliminary findings from a pilot study. Int Public Health J. 2019;11(2):185–95.
Baron D, Scorgie F, Ramskin L, Khoza N, Schutzman J, Stangl A, et al. “You talk about problems until you feel free”: South African adolescent girls’ and young women’s narratives on the value of HIV prevention peer support clubs. BMC Public Health. 2020;20(1):1–13.
Delany-Moretlwe S, Chersich M, Harvey S, Stangl A, Baron D, Columbini M, et al. Empowerment clubs did not increase PrEP continuation in AGYW in South Africa & Tanzania-results from EMPOWER trial. In: International AIDS Conference. Amsterdam; 2018.
Stangl AL, Lilleston P, Mathema H, Pliakas T, Krishnaratne S, Sievwright K, et al. Development of parallel measures to assess HIV stigma and discrimination among people living with HIV, community members and health workers in the HPTN 071 (PopART) trial in Zambia and South Africa. J Int AIDS Soc. 2019. https://doi.org/10.1002/jia2.25421.
Brooks RA, Landrian A, Nieto O, Fehrenbacher A. Experiences of anticipated and enacted pre-exposure prophylaxis (PrEP) stigma among Latino MSM in Los Angeles. AIDS Behav. 2019;23(7):1964–73.
Baron EC, Davies T, Lund C. Validation of the 10-item Centre for Epidemiological Studies Depression Scale (CES-D-10) in Zulu, Xhosa and Afrikaans populations in South Africa. BMC Psychiatry. 2017. https://doi.org/10.1186/s12888-016-1178-x.
Balkus JE, Brown E, Palanee T, Nair G, Gafoor Z, Zhang J, et al. An empiric HIV risk scoring tool to predict HIV-1 acquisition in African women. J Acquir Immune Defic Syndr. 2016;72(3):333–43.
Colombini M, Scorgie F, Stangl A, Harvey S, Ramskin L, Khoza N, et al. Exploring the feasibility and acceptability of integrating screening for gender-based violence into HIV counselling and testing for adolescent girls and young women in Tanzania and South Africa. BMC Public Health. 2021;21(1):1–11.
Saunders JB, Aasland, Olaf G, Babor TF, De la Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction. 1993;88(6):791–804.
Reinert DF, Allen JP. The alcohol use disorders identification test: an update of research findings. 2007 [cited 2021 Jul 20]. Available from: http://www.who.int/substance_abuse/.
Knight J, Sherritt L, Harris S, Gates E, Chang G. Validity of brief alcohol screening tests among adolescents: a comparison of the AUDIT, POSIT, CAGE, and CRAFFT. Addiction. 2003;27(1):67–73.
Reisner SL, Moore CS, Asquith A, Pardee DJ, Sarvet A, Mayer G, et al. High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States. J Int AIDS Soc. 2019. https://doi.org/10.1002/jia2.25391.
Maughan-Brown B, Venkataramani A, Kharsany AB, Beckett S, Govender K, Lewis L, et al. Recently formed age-disparate partnerships are associated with elevated HIV-incidence among young women in South Africa. AIDS. 2020;34(1):149.
Wamoyi J, Stoebenau K, Kyegombe N, Heise L, Ranganathan M. Measuring transactional sex and HIV risk: technical brief. London; 2017.
Nunnally JC. Assessment of reliability. In: Psychometric theory. 2nd ed. New York: McGraw-Hill; 1978. p. 1–701.
Jain JP, Strathdee SA, Patterson TL, Semple SJ, Harvey-Vera A, Magis-Rodríguez C, et al. Perceived barriers to pre-exposure prophylaxis use and the role of syndemic factors among female sex workers in the Mexico-United States border region: a latent class analysis. AIDS Care. 2020;32(5):557–66.
Collins L, Lanza S. Latent class and latent transition analysis: with applications in the social, behavioral, and health science. Hoboken: Wiley; 2010. p. 295.
Muthén L, Muthén O. Mplus user guide version 8.0. Los Angeles; 2018. 950 p.
Berlin KS, Williams NA, Parra GR. An introduction to latent variable mixture modeling (part 1): overview and cross-sectional latent class and latent profile analyses. J Pediatr Psychol. 2014;39:174–87.
Celeux G, Martin-Magniette M-L, Maugis-Rabusseau C, Raftery AE. Comparing model selection and regularization approaches to variable selection in model-based clustering. Journal de la Societe francaise de statistique. 2014;155(2):57–71.
Anderson D. Model based inference in the life sciences—a primer on evidence. New York: Springer-Verlag; 2008. p. 184.
Nyblade L, MacQuarrie K, Phillip F, Kwesigabo G, Mbwambo J, Ndega J, Katende C, Yuan E, Brown L, Stangl A. Working report-measuring HIV stigma: results of a field test in Tanzania. Washington, DC; 2005.
Phillips G, Raman A, Felt D, Han Y, Mustanski B. Factors associated with PrEP support and disclosure among YMSM and transgender individuals assigned male at birth in Chicago. AIDS Behav. 2019;23(10):2749–60.
Stangl A, Bryan C, Barre I, Lees S, Ramskin L, Khoza N, et al. The influence of stigma on PrEP uptake among adolescent girls and young women in Johannesburg, South Africa and Mwanza, Tanzania: qualitative findings from the EMPOWER study. In: AIDS Impact Conference. London; 2019.
Golub SA. PrEP stigma: implicit and explicit drivers of disparity. Curr HIV/AIDS Rep. 2018;15(2):190–7.
Chittamuru D, Frye V, Koblin BA, Brawner B, Tieu H-V, Davis A, et al. PrEP stigma, HIV stigma, and intention to use PrEP among women in New York City and Philadelphia. Stigma Health. 2020;5(2):240–6.